Themis Medicare's 56th AGM: Shareholders Approve All Resolutions, Including Dividend Declaration
Themis Medicare Limited's 56th AGM on September 30, 2026, saw all resolutions passed, including financial statement adoption, director re-appointment, and dividend declaration. Shareholders approved the company's audited financial statements for FY26 and ratified cost auditor remuneration. The Articles of Association were also amended.
The AGM results are routine for a company of this nature. While the passing of resolutions and dividend declaration are positive, they do not represent a significant strategic shift or major financial event that would drastically alter the company's market position.
All resolutions were passed by shareholders with the requisite majority, indicating positive shareholder support for the company's decisions and financial performance.
Themis Medicare Limited has announced the results of its 56th Annual General Meeting (AGM) held on Wednesday, 30th September, 2026. The company submitted the Scrutinizer’s Report along with the voting results, which included outcomes from remote e-voting and voting via ballot paper during the AGM.
All resolutions presented at the meeting were passed by the shareholders with the requisite majority. These resolutions included the adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended 31st March 2026, the re-appointment of Mr. Rajneesh Anand as a Director, the declaration of dividend for the financial year ended 31st March 2026, the ratification of remuneration for the Cost Auditor for the Financial Year 2026-27, and an amendment to the Articles of Association of the Company.
The detailed voting results and the Scrutinizer’s Report have been uploaded to the company's website and CDSL for public access. The Chairman & Director, Mr. Dinesh S. Patel, confirmed the passing of all resolutions.
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.